Skip to main content
. 2024 Sep 23;15:1401962. doi: 10.3389/fimmu.2024.1401962

Table 3.

DNA methylation and Parkinson’s disease (PD).

Gene/
protein
Function Mechanism Reference
SNCA Contributing to PD pathology Increasing accumulation of α-synuclein and ROS production, affecting dopaminergic neuron function (193)
TMCC2 Contributing to PD pathology Forming complexes with APOE and APP, regulating to Braak Lewy body staging (189)
SLC7A11 A biological target in PD Transporting cystine and glutamate, disrupting glutathione levels and increasing oxidative stress (190)
HOTAIR Promoting neurodegeneration in PD Influencing ERK1/2 signaling (191)
PARK7 Protecting cells from oxidative stress in PD Impairing antioxidant function and resulting in dopaminergic neuron loss (192)
SLC17A6 Transporting glutamate in PD Altering neurotransmitter release and vesicular transport (192)
PTPRN2 Protecting from PD Impacting the function of insulin signaling-related proteins (192)
NR4A2 Protecting from PD Affecting the development and function of dopaminergic neurons (192)